BAX
Price
$25.65
Change
+$0.95 (+3.85%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
12.77B
7 days until earnings call
Intraday BUY SELL Signals
TELA
Price
$1.01
Change
-$0.07 (-6.48%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
48.75M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BAX vs TELA

BAX vs TELA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BAX vs. TELA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and TELA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BAX with price predictions
Oct 21, 2026

Aroon Indicator for BAX shows an upward move is likely

BAX's Aroon Indicator triggered a bullish signal on October 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator showed a similar pattern. In 143 of the 210 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 30, 2026. You may want to consider a long position or call options on BAX as a result. In 53 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for BAX just turned positive on September 30, 2026. Looking at past instances where BAX's MACD turned positive, the stock continued to rise in 23 of 45 cases over the following month. The odds of a continued upward trend are 51%.

Following a +2.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAX advanced for three days, in 165 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

Bearish Trend Analysis

The 10-day RSI Indicator for BAX moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 20 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 55 cases where BAX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.

BAX moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

BAX broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 18 (best 1 - 100 worst), indicating outstanding price growth. BAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.058) is normal, around the industry mean (4.952). P/E Ratio (-11.932) is within average values for comparable stocks, (36.644). BAX's Projected Growth (PEG Ratio) (36.677) is very high in comparison to the industry average of (4.143). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (1.057) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for TELA with price predictions
Oct 21, 2026

TELA's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for TELA moved out of overbought territory on September 24, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In 18 of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TELA turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 40 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

TELA broke above its upper Bollinger Band on September 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 68 cases where TELA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TELA as a result. In 78 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

Following a +12.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where TELA advanced for three days, in 174 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

The Aroon Indicator entered an Uptrend today. In 112 of 136 cases where TELA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.073) is normal, around the industry mean (2.923). P/E Ratio (-1.403) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.782) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. TELA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
BAX vs TELA: Fundamental Ratings
BAX
TELA
OUTLOOK RATING
1..100
1161
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
1839
P/E GROWTH RATING
1..100
5488
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TELA's Valuation (31) in the null industry is somewhat better than the same rating for BAX (96) in the Medical Specialties industry. This means that TELA’s stock grew somewhat faster than BAX’s over the last 12 months.

TELA's Profit vs Risk Rating (100) in the null industry is in the same range as BAX (100) in the Medical Specialties industry. This means that TELA’s stock grew similarly to BAX’s over the last 12 months.

BAX's SMR Rating (94) in the Medical Specialties industry is in the same range as TELA (100) in the null industry. This means that BAX’s stock grew similarly to TELA’s over the last 12 months.

BAX's Price Growth Rating (18) in the Medical Specialties industry is in the same range as TELA (39) in the null industry. This means that BAX’s stock grew similarly to TELA’s over the last 12 months.

BAX's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for TELA (88) in the null industry. This means that BAX’s stock grew somewhat faster than TELA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXTELA
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
57%
Bullish Trend about 1 month ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 7 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BAX: $24.70 vs. TELA: $1.08)
Brand notoriety: BAX and TELA are both not notable
BAX represents the Pharmaceuticals: Other, while TELA is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 89% vs. TELA: 22%
Market capitalization -- BAX: $12.77B vs. TELA: $45.59M
BAX [@Pharmaceuticals: Other] is valued at $12.77B. TELA’s [@Medical/Nursing Services] market capitalization is $45.59M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 1 FA rating(s) are green while TELA’s FA Score has 1 green FA rating(s).

  • BAX’s FA Score: 1 green, 4 red.
  • TELA’s FA Score: 1 green, 4 red.
According to our system of comparison, TELA is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while TELA’s TA Score has 4 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 5 bearish.
  • TELA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TELA is a better buy in the short-term than BAX.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а -0.40% price change this week, while TELA (@Medical/Nursing Services) price change was -1.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

BAX is expected to report earnings on Oct 29, 2026.

TELA is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BAX
Daily Signal:
Gain/Loss:
TELA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

TELA and

Correlation & Price change

A.I.dvisor tells us that TELA and BAX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and BAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELA
1D Price
Change %
TELA100%
-0.92%
BAX - TELA
28%
Poorly correlated
+0.78%
AMIX - TELA
27%
Poorly correlated
-1.53%
HBIO - TELA
27%
Poorly correlated
+1.80%
TFX - TELA
27%
Poorly correlated
-0.57%
AZTA - TELA
26%
Poorly correlated
+2.88%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GLOW34.620.15
+0.44%
VictoryShares WestEnd Global Equity ETF (GLOW)
TSYX23.040.10
+0.44%
TSPY Lift ETF (TSYX)
FTMN8.330.01
+0.06%
Franklin Minnesota Municipal Income ETF (FTMN)
YHNA11.13N/A
N/A
YHN Acquisition I Ltd
GGLL93.45-3.07
-3.18%
Direxion Daily GOOGL Bull 2X ETF (GGLL)